<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045860"><TermName>rebeccamycin</TermName><TermPronunciation>(reh-BEH-kuh-MY-sin)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called antineoplastic antibiotics.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731249" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;rebeccamycin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731248" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;rebecamicina&quot;" language="es" id="_4"/><SpanishTermName>rebecamicina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del cáncer. Pertenece al tipo de medicamentos llamados antibióticos antineoplásicos.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2005-01-20</DateLastModified></GlossaryTerm>
